Literature DB >> 26448158

Type II focal cortical dysplasia: Ex vivo 7T magnetic resonance imaging abnormalities and histopathological comparisons.

Ileana Zucca1, Gloria Milesi2, Valentina Medici2, Laura Tassi3, Giuseppe Didato2, Francesco Cardinale3, Giovanni Tringali4, Nadia Colombo5, Manuela Bramerio6, Ludovico D'Incerti7, Elena Freri8, Michela Morbin9, Valeria Fugnanesi9, Matteo Figini1, Roberto Spreafico2, Rita Garbelli2.   

Abstract

OBJECTIVE: In the present report, the correlations between ex vivo high-resolution imaging and specific histological and ultrastructural patterns in type II focal cortical dysplasia (FCD) have been studied to explain the differences in the magnetic resonance imaging (MRI) detection of dysplasia and to contribute to the presurgical imaging evaluation of this pathology.
METHODS: Surgical specimens from 13 patients with FCD IIa/b were submitted to 7T MRI scanning, and then analyzed histologically and ultrastructurally to compare the results with the MRI findings. Region of interest (ROI)-based measures on T2-weighted images (T2wi) were quantitatively evaluated in the lesion and in adjacent perilesional gray and white matter.
RESULTS: Matched histological sections and 7T T2wi showed that the core of the lesion was characterized by patchy aggregates of abnormal cells and fiber disorganization related to inhomogeneity of intracortical signal intensity. The quantitative approach on T2wi can help to distinguish the lesions and perilesional areas even in a clinical MRI-negative case. The ultrastructural study showed that the strong signal hyperintensity in the white matter of FCD IIb was related to a dysmyelination process associated with severe fiber loss and abnormal cells. Less severe histopathological features were found in FCD IIa, thus reflecting their less evident MRI alterations.
INTERPRETATION: We suggest that white matter abnormalities in type IIb FCD are due to defects of the myelination processes and maturation, impaired by the presence of balloon cells. To reveal the presence and the border of type II cortical dysplasia on MRI, a quantitative ROI-based analysis (coefficient of variation) is also proposed.
© 2015 American Neurological Association.

Entities:  

Mesh:

Year:  2015        PMID: 26448158     DOI: 10.1002/ana.24541

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

Review 1.  Review: The past, present and future challenges in epilepsy-related and sudden deaths and biobanking.

Authors:  M Thom; M Boldrini; E Bundock; M N Sheppard; O Devinsky
Journal:  Neuropathol Appl Neurobiol       Date:  2018-02       Impact factor: 8.090

2.  A within-coil optical prospective motion-correction system for brain imaging at 7T.

Authors:  Phillip DiGiacomo; Julian Maclaren; Murat Aksoy; Elizabeth Tong; Mackenzie Carlson; Bryan Lanzman; Syed Hashmi; Ronald Watkins; Jarrett Rosenberg; Brian Burns; Timothy W Skloss; Dan Rettmann; Brian Rutt; Roland Bammer; Michael Zeineh
Journal:  Magn Reson Med       Date:  2020-02-20       Impact factor: 4.668

3.  Multimodal MRI profiling of focal cortical dysplasia type II.

Authors:  Seok-Jun Hong; Boris C Bernhardt; Benoit Caldairou; Jeffery A Hall; Marie C Guiot; Dewi Schrader; Neda Bernasconi; Andrea Bernasconi
Journal:  Neurology       Date:  2017-01-27       Impact factor: 9.910

4.  Ultra-High-Field Targeted Imaging of Focal Cortical Dysplasia: The Intracortical Black Line Sign in Type IIb.

Authors:  E Bartolini; M Cosottini; M Costagli; C Barba; L Tassi; R Spreafico; R Garbelli; L Biagi; A Buccoliero; F Giordano; R Guerrini
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

Review 5.  Striking MRI Changes of Focal Cortical Dysplasia Over Time: A Case Series and Literature Review.

Authors:  Adina Achiriloaie; Jeremy Deisch; Warren Boling; Firas Bannout
Journal:  Neurol Clin Pract       Date:  2021-10

6.  Can histologically normal epileptogenic zone share common electrophysiological phenotypes with focal cortical dysplasia? SEEG-based study in MRI-negative epileptic patients.

Authors:  Stanislas Lagarde; Julia Scholly; Irina Popa; Maria Paola Valenti-Hirsch; Agnès Trebuchon; Aileen McGonigal; Mathieu Milh; Anke M Staack; Béatrice Lannes; Benoît Lhermitte; François Proust; Mustapha Benmekhbi; Didier Scavarda; Romain Carron; Dominique Figarella-Branger; Edouard Hirsch; Fabrice Bartolomei
Journal:  J Neurol       Date:  2019-05-04       Impact factor: 4.849

7.  Value of 7T MRI and post-processing in patients with nonlesional 3T MRI undergoing epilepsy presurgical evaluation.

Authors:  Irene Wang; Sehong Oh; Ingmar Blümcke; Roland Coras; Balu Krishnan; Sanghoon Kim; Aaron McBride; Olesya Grinenko; Yicong Lin; Margit Overmyer; Tin Tun Aung; Mark Lowe; Mykol Larvie; Andreas V Alexopoulos; William Bingaman; Jorge A Gonzalez-Martinez; Imad Najm; Stephen E Jones
Journal:  Epilepsia       Date:  2020-09-19       Impact factor: 5.864

8.  Hyperactive mTOR signals in the proopiomelanocortin-expressing hippocampal neurons cause age-dependent epilepsy and premature death in mice.

Authors:  Yuki Matsushita; Yasunari Sakai; Mitsunori Shimmura; Hiroshi Shigeto; Miki Nishio; Satoshi Akamine; Masafumi Sanefuji; Yoshito Ishizaki; Hiroyuki Torisu; Yusaku Nakabeppu; Akira Suzuki; Hidetoshi Takada; Toshiro Hara
Journal:  Sci Rep       Date:  2016-03-10       Impact factor: 4.379

Review 9.  Key clinical benefits of neuroimaging at 7T.

Authors:  Siegfried Trattnig; Elisabeth Springer; Wolfgang Bogner; Gilbert Hangel; Bernhard Strasser; Barbara Dymerska; Pedro Lima Cardoso; Simon Daniel Robinson
Journal:  Neuroimage       Date:  2016-11-13       Impact factor: 6.556

10.  Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.

Authors:  Theresa Scholl; Angelika Mühlebner; Gerda Ricken; Victoria Gruber; Anna Fabing; Sharon Samueli; Gudrun Gröppel; Christian Dorfer; Thomas Czech; Johannes A Hainfellner; Avanita S Prabowo; Roy J Reinten; Lisette Hoogendijk; Jasper J Anink; Eleonora Aronica; Martha Feucht
Journal:  Brain Pathol       Date:  2017-02-09       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.